Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Preclinical studies support potential of CP-358774 as cancer treatment

Feb. 4, 1998

Newly identified human natural killer cell-activating factor reported by HGS

Feb. 3, 1998

Pharmacological profile of new alkylating agent from Menarini

Feb. 3, 1998

Structure of new IL-6 inhibitors determined at Kitasato Institute

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Phase I/II trial results reported for Neovastat in lung cancer

Jan. 30, 1998

Hybridon antitumor antisense compound enters clinical trials

Jan. 29, 1998

Pacific's cancer immunotherapy proves highly effective in rat metastatic mammary tumor model

Jan. 28, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Flavopiridol analogues as inhibitors of cyclin-dependent kinases

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...